First U-M Patient Receives Newly FDA-approved Stem Cell Therapy for Sickle Cell Anemia
April 16, 2026
April 16, 2026
ANN ARBOR, Michigan, April 16 -- Michigan Medicine, the academic medical center of the University of Michigan, issued the following news release:
* * *
First U-M patient receives newly FDA-approved stem cell therapy for sickle cell anemia
Elijah Dottery, 10, underwent several treatments, including a bone marrow transplant, for his condition
*
Sickle cell disease affects about 100,000 people in the United States and millions worldwi . . .
* * *
First U-M patient receives newly FDA-approved stem cell therapy for sickle cell anemia
Elijah Dottery, 10, underwent several treatments, including a bone marrow transplant, for his condition
*
Sickle cell disease affects about 100,000 people in the United States and millions worldwi . . .